Prognostic Significance of Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score in Hepatocellular Carcinoma

References

• Zhou J, Sun HC, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition). 中华人民共和国国家卫生健康委员会医政医管局, 原发性肝癌诊疗规范(2019年版). 中华肝脏病杂志. Liver Cancer. 2020;9(6):682–720. Chinese. doi:10.1159/000509424
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–1362. doi:10.1016/S0140-6736(22)01200-4
   PubMed Web of Science ®Google Scholar
• Kok B, Abraldes JG. Child-Pugh classification: time to abandon? Semin Liver Dis. 2019;39(1):96–103. doi:10.1055/s-0038-1676805
   PubMed Web of Science ®Google Scholar
• Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317–370. doi:10.1007/s12072-017-9799-9
   PubMed Web of Science ®Google Scholar
• Yang JD, Larson JJ, Watt KD, et al. Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the United States. Clin Gastroenterol Hepatol. 2017;15(5):767–75.e3. doi:10.1016/j.cgh.2016.11.034
   PubMed Web of Science ®Google Scholar
• Salem R, Tselikas L, De Baere T. Interventional treatment of hepatocellular carcinoma. J Hepatol. 2022;77(4):1205–1206. doi:10.1016/j.jhep.2022.03.037
   PubMed Web of Science ®Google Scholar
• Huang A, Yang XR, Chung WY, Dennison AR, Zhou J. Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther. 2020;5(1):146. doi:10.1038/s41392-020-00264-x
   PubMed Web of Science ®Google Scholar
• Cai R, Song R, Pang P, et al. Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis. BMC Cancer. 2017;17(1):714. doi:10.1186/s12885-017-3707-5
   PubMedGoogle Scholar
• Liu Z, Liu X, Liang J, et al. Immunotherapy for hepatocellular carcinoma: current status and future prospects. Front Immunol. 2021;12:765101. doi:10.3389/fimmu.2021.765101
   PubMed Web of Science ®Google Scholar
• Oura K, Morishita A, Tani J, Masaki T. Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review. Int J Mol Sci. 2021;22(11):5801. doi:10.3390/ijms22115801
   PubMed Web of Science ®Google Scholar
• Minici R, Siciliano MA, Ammendola M, et al. Prognostic role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: the unexplored corner linking tumor microenvironment, biomarkers and interventional radiology. Cancers. 2022;15(1). doi:10.3390/cancers15010257
   PubMed Web of Science ®Google Scholar
• Schobert IT, Savic LJ, Chapiro J, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Eur Radiol. 2020;30(10):5663–5673. doi:10.1007/s00330-020-06931-5
   PubMed Web of Science ®Google Scholar
• George ES, Sood S, Broughton A, et al. The association between diet and hepatocellular carcinoma: a systematic review. Nutrients. 2021;13(1):172. doi:10.3390/nu13010172
   PubMed Web of Science ®Google Scholar
• Jiang Y, Tu X, Zhang X, et al. Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy. Support Care Cancer. 2020;28(11):5569–5579. doi:10.1007/s00520-020-05478-x
   PubMed Web of Science ®Google Scholar
• Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243–274. doi:10.3322/caac.21142
   PubMed Web of Science ®Google Scholar
• Xu H, Zheng X, Ai J, Yang L. Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: a systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol. 2023;114:109496. doi:10.1016/j.intimp.2022.109496
   PubMed Web of Science ®Google Scholar
• Xu SS, Li S, Xu HX, et al. Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. World J Gastroenterol. 2020;26(8):828–838. doi:10.3748/wjg.v26.i8.828
   PubMed Web of Science ®Google Scholar
• Zhao Z, Yin XN, Wang J, Chen X, Cai ZL, Zhang B. Prognostic significance of hemoglobin, albumin, lymphocyte, platelet in gastrointestinal stromal tumors: a propensity matched retrospective cohort study. World J Gastroenterol. 2022;28(27):3476–3487. doi:10.3748/wjg.v28.i27.3476
   PubMed Web of Science ®Google Scholar
• Hu SJ, Zhao XK, Song X, et al. Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma. World J Gastroenterol. 2021;27(4):321–335. doi:10.3748/wjg.v27.i4.321
   PubMed Web of Science ®Google Scholar
• Lemoine M, Shimakawa Y, Nayagam S, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016;65(8):1369–1376. doi:10.1136/gutjnl-2015-309260
   PubMed Web of Science ®Google Scholar
• Zhang W, Sun M, Chen G, et al. Reassessment of gamma-glutamyl transpeptidase to platelet ratio (GPR): a large-sample, dynamic study based on liver biopsy in a Chinese population with chronic hepatitis B virus (HBV) infection. Gut. 2018;67(5):989–991. doi:10.1136/gutjnl-2017-313896
   PubMed Web of Science ®Google Scholar
• Park YE, Kim BK, Park JY, et al. Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer. J Gastroenterol Hepatol. 2017;32(6):1221–1229. doi:10.1111/jgh.13653
   PubMed Web of Science ®Google Scholar
• Liang LY, Lee HW, Wong VW, et al. Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B. Clin Mol Hepatol. 2021;27(3):499–509. doi:10.3350/cmh.2020.0333
   PubMed Web of Science ®Google Scholar
• Tamaki N, Kurosaki M, Yasui Y, et al. Change in fibrosis 4 index as predictor of high risk of incident hepatocellular carcinoma after eradication of hepatitis C virus. Clin Infect Dis. 2021;73(9):e3349–e3354. doi:10.1093/cid/ciaa1307
   PubMed Web of Science ®Google Scholar
• Cholankeril G, Kramer JR, Chu J, et al. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol. 2022;78(3):493–500. doi:10.1016/j.jhep.2022.10.035
   PubMed Web of Science ®Google Scholar
• Ke MY, Zhang M, Su Q, et al. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection. J Surg Res. 2018;231:403–410. doi:10.1016/j.jss.2018.05.049
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang T, Xu L, Wang P, Zhang M, Xu M. Development and validation of a prognostic model based on the albumin-to-fibrinogen ratio (AFR) and gamma-glutamyl transpeptidase-to-platelet ratio (GPR) in hepatocellular carcinoma patients. Clin Chim Acta. 2020;511:107–116. doi:10.1016/j.cca.2020.09.038
   PubMed Web of Science ®Google Scholar
• Feng JW, Qu Z, Wu BQ, Sun DL, Jiang Y. The preoperative fibrosis score 4 predicts posthepatectomy liver failure in patients with hepatocellular carcinoma. Ann Hepatol. 2019;18(5):701–707. doi:10.1016/j.aohep.2019.04.017
   PubMed Web of Science ®Google Scholar
• Lin PT, Teng W, Jeng WJ, et al. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients. J Formos Med Assoc. 2020;119(2):635–643. doi:10.1016/j.jfma.2019.08.019
   PubMed Web of Science ®Google Scholar
• Zhou P, Chen B, Miao XY, et al. Comparison of FIB-4 index and Child-Pugh score in predicting the outcome of hepatic resection for hepatocellular carcinoma. J Gastrointest Surg. 2020;24(4):823–831. doi:10.1007/s11605-019-04123-1
   PubMed Web of Science ®Google Scholar
• Yoshimasu Y, Furuichi Y, Kasai Y, et al. Predictive factors for hepatocellular carcinoma occurrence or recurrence after direct-acting antiviral agents in patients with chronic hepatitis C. J Gastrointestin Liver Dis. 2019;28(1):63–71. doi:10.15403/jgld.2014.1121.281.hpc
   PubMed Web of Science ®Google Scholar
• Choi WM, Lee JH, Ahn H, et al. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection. Liver Int. 2015;35(8):1992–2000. doi:10.1111/liv.12776
   PubMed Web of Science ®Google Scholar
• Peng Z, Chen S, Xiao H, et al. Microvascular invasion as a predictor of response to treatment with sorafenib and transarterial chemoembolization for recurrent intermediate-stage hepatocellular carcinoma. Radiology. 2019;292(1):237–247. doi:10.1148/radiol.2019181818
   PubMed Web of Science ®Google Scholar
• Wu W, Wang Q, Han D, et al. Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection. Cancer Cell Int. 2021;21(1):500. doi:10.1186/s12935-021-02204-3
   PubMed Web of Science ®Google Scholar
• Belcher DA, Ju JA, Baek JH, et al. The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: a theoretical and experimental study. PLoS One. 2018;13(2):e0191275. doi:10.1371/journal.pone.0191275
   PubMed Web of Science ®Google Scholar
• Xia L, Hu G, Guzzo TJ. Prognostic significance of preoperative anemia in patients undergoing surgery for renal cell carcinoma: a meta-analysis. Anticancer Res. 2017;37(6):3175–3181. doi:10.21873/anticanres.11677
   PubMed Web of Science ®Google Scholar
• Cabrerizo S, Cuadras D, Gomez-Busto F, Artaza-Artabe I, Marín-Ciancas F, Malafarina V. Serum albumin and health in older people: review and meta analysis. Maturitas. 2015;81(1):17–27. doi:10.1016/j.maturitas.2015.02.009
   PubMed Web of Science ®Google Scholar
• Eckart A, Struja T, Kutz A, et al. Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. Am J Med. 2020;133(6):713–22.e7. doi:10.1016/j.amjmed.2019.10.031
   PubMed Web of Science ®Google Scholar
• Ataseven B, du Bois A, Reinthaller A, et al. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol. 2015;138(3):560–565. doi:10.1016/j.ygyno.2015.07.005
   PubMed Web of Science ®Google Scholar
• Lei J, Wang Y, Guo X, et al. Low preoperative serum ALB level is independently associated with poor overall survival in endometrial cancer patients. Future Oncol. 2020;16(8):307–316. doi:10.2217/fon-2019-0732
   PubMed Web of Science ®Google Scholar
• Martínez-Lostao L, Anel A, Pardo J. How do cytotoxic lymphocytes kill cancer cells? Clin Cancer Res. 2015;21(22):5047–5056. doi:10.1158/1078-0432.CCR-15-0685
   PubMed Web of Science ®Google Scholar
• Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):360. doi:10.1186/s12916-020-01817-1
   PubMed Web of Science ®Google Scholar
• Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell. 2018;33(6):965–983. doi:10.1016/j.ccell.2018.03.002
   PubMed Web of Science ®Google Scholar
• Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol. 2018;11(1):125. doi:10.1186/s13045-018-0669-2
   PubMed Web of Science ®Google Scholar
• Roweth HG, Battinelli EM. Lessons to learn from tumor-educated platelets. Blood. 2021;137(23):3174–3180. doi:10.1182/blood.2019003976
   PubMed Web of Science ®Google Scholar
• Best MG, Wesseling P, Wurdinger T. Tumor-educated platelets as a noninvasive biomarker source for cancer detection and progression monitoring. Cancer Res. 2018;78(13):3407–3412. doi:10.1158/0008-5472.CAN-18-0887
   PubMed Web of Science ®Google Scholar
• Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261–6272. doi:10.3748/wjg.v23.i34.6261
   PubMed Web of Science ®Google Scholar
• Li B, Zhou P, Liu Y, et al. Platelet-to-lymphocyte ratio in advanced cancer: review and meta-analysis. Clin Chim Acta. 2018;483:48–56. doi:10.1016/j.cca.2018.04.023
   PubMed Web of Science ®Google Scholar
• Li SP, Cao D, He JH, Lou MG, Tu XX, Li Y. High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysis. Expert Rev Gastroenterol Hepatol. 2022;16(2):193–199. doi:10.1080/17474124.2022.2031977
   PubMed Web of Science ®Google Scholar